Selcia Limited Company Profile
Selcia Limited is a privately held contract research organisation with two operating divisions, Selcia Discovery and Selcia Radiolabelling, Selcia Discovery, with a track record of delivering robust clinical candidates, and Selcia Radiolabelling, a world leader in C-14 custom synthesis, are the operating divisions of Selcia located in Essex, to the northeast of London.Selcia Radiolabelling is the partner of choice for carbon-14 radiosynthesis worldwide. We offer a level of personal service and dedication equivalent to an internal isotope laboratory, taking care of your all your radiolabelling needs or supporting internal groups in times of peak demand.
Selcia Discovery has significant research partnerships with leading pharmaceutical and biotechnology companies. We specialise in fragment based drug discovery and providing medicinal chemistry to support academic institutions and small biotech companies. We continue to seek partnerships with major companies for drug discovery projects in all therapeutic areas.
Both divisions are supported by our GLP MHRA accredited laboratory where our analysts, experienced in structural biology, structural elucidation and impurity profiling operate with exceptional infrastructure including three high-field NMR spectrometers to ensure the quality of your services.
Fyfield Business & Research Park
Phone: + 44 (0) 1277 367 000
Fax: + 44 (0) 1277 367 099
Contract life science research services company Selcia Limited has announced the demerger of all internally generated intellectual property into two new companies, Mitopharm Ltd and Selcia Pharma Ltd....
Forms Mitopharm and Selcia Pharma to protect IP while attracting external investment
27 November 2012: Ongar, UK – OBN Member Selcia, the international CRO, has announced the launch of a new platform to enable drug discovery and development on the target family of ...
30 October 2012: Ongar, UK - Selcia Limited, a global leader in 14C radiolabelling and integrated drug discovery service provider, has received GLP re-certification for its analytical laboratory ...
20 September 2012: Ongar, UK – . Selcia Limited, the international life sciences contract research organisation, has been granted a UK patent for the technology platform underpinning the ...
30 July 2012: Ongar, UK – Selcia Limited, the global provider of contract research services to the life sciences industry, has today announced the demerger of all internally generated ...
08 October 2012: Ongar, UK and Lund Sweden - UK-based Mitopharm Limited, a subsidiary of Selcia Holdings Limited, and Swedish drug development company NeuroVive Pharmaceutical AB have developed ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted good laboratory practice (GLP) re-certification to Selcia's analytical laboratory.
Drugs and Medications
Selcia Limited (www.selcia.com) is a leading worldwide provider of contract research services in integrated drug discovery, fragment screening, medicinal chemistry and GMP...
Selcia Limited is a privately held contract research organisation with two operating divisions, Selcia Discovery and Selcia Radiolabelling, Selcia Discovery, with a track record of delivering robust...
Selcia Ltd is a privately held company providing both carbon-14 (C-14) radiolabelling and integrated drug discovery services, operating from a modern facility in Ongar, Essex, UK....
Convergence Pharmaceuticals is an independent biotechnology company focused on the development of novel analgesics with potentially commercially attractive efficacy, responder-rat...
More Information about "Selcia Limited" on BioPortfolio
We have published hundreds of Selcia Limited news stories on BioPortfolio along with dozens of Selcia Limited Clinical Trials and PubMed Articles about Selcia Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Selcia Limited Companies in our database. You can also find out about relevant Selcia Limited Drugs and Medications on this site too.